NIG-GERMAN - Nigeria-German Chemicals
Manufacturing, Marketing/Sales & Distribution of Pharmaceutical health products, household consumer products and oilfield chemical.
|Last Trading Results||Growth & Valuation|
|Opening Price:||--||Earnings Per Share:||--|
|Day's Low Price:||--||Price/Earning Ratio:||--|
|Day's High Price:||--||Dividend Per Share:||--|
|Traded Volume:||100||Dividend Yield:||--|
|Number of Deals:||1||Shares Outstanding:||153.79m|
Monetary values are quoted in Nigerian Naira (NGN) unless otherwise stated
NIG-GERMAN Market Performance
NIG-GERMAN currently ranks 71st on the Nigerian Stock Exchange in terms of returns to investors with a year-to-date return of zero percent. Following NIG-GERMAN are AFRIPRUD (-0.34%), CAPHOTEL (-0.57%), and INFINITY (-2.04%). Shareholders are anxiously awaiting when Nigeria-German Chemicals will announce dividends to see whether they have gained something or not. Below is the historical trading trend of NIG-GERMAN, covering up to the last 10 trading sessions of activity.
Profile of Nigeria-German Chemicals
Nigeria-German Chemicals operates in the Health Care sector, specifically, the Pharmaceuticals industry—according to the reverse Industry Classification Benchmark (ICB) taxonomy. We are sorry that the names of Nigeria-German Chemicals's board of directors are temporarily unavailable.
|Factsheet of Nigeria-German Chemicals|
Industrial Stock Market Competitors
Nigeria-German Chemicals, issuers of the NIG-GERMAN stock on the Nigerian Stock Exchange, have seven market competitors who are also engaged in the Health Care/Pharmaceuticals industry. The table below gives you an overview of their market standing.
|GLAXOSMITH||Glaxo Smithkline Consumer||25.82b||20.45||+0.00|
|MAYBAKER||May & Baker Nigeria||4.47b||4.74||-0.24|
|NEIMETH||Neimeth International Pharma||1.17b||0.98||+0.06|
|EVANSMED||Evans Medical Plc||366.17m||0.50||+0.00|